Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Hematologic Diseases × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Neuroendocrine Tumors 1 Intestinal Neoplasms 1 Hematopoietic Recovery 1 Hematologic Diseases 1 HER2 Low Breast Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

fludarabine phosphate 1 fludarabine 1 Injections 1 Cyclophosphamide 1 COVID-19 Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05755854 2023-09-22

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Anhui Provincial Hospital

Phase 1 Unknown

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡